The Committee adopted 10 positive opinions on orphan medicinal product designation during this meeting: — Arsenic trioxide, Cephalon Europe, for treatment of acute myeloid leukaemia (review time: day 62) — Ciprofloxacin (inhalation use), from Bayer Healthcare AG, for treatment of c [click link for full article]
More: continued here